カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のムピロシン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Mupirocin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8898）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8898
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のムピロシン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ムピロシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のムピロシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ムピロシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・クリーム、軟膏、その他

用途別セグメントは次のように区分されます。
・一次感染、二次感染

世界のムピロシン市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Medimetriks Pharmaceuticals、Cardinal Health、Ortho-McNeil Pharmaceutical、Glenmark Pharmaceuticals、Taro Pharmaceuticals、BIOMES PHARMACEUTICALS、H.J. Harkins Company、Directrx、Teva Pharmaceuticals、Fougera Pharmaceuticals、Profcient、Remedy Repack、Lohxa、Nucare Pharmaceuticals、Sino-american Tianjin Shike Pharmaceutical、Hangzhou Zhuyangxin Pharmaceutical、Hubei Renfu Chengtian Pharmaceutical、Hong Kong Aomei Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ムピロシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なムピロシンメーカーの企業概要、2019年～2022年までのムピロシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なムピロシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ムピロシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのムピロシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのムピロシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびムピロシンの産業チェーンを掲載しています。
・第13、14、15章では、ムピロシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GSK、Medimetriks Pharmaceuticals、Cardinal Health、Ortho-McNeil Pharmaceutical、Glenmark Pharmaceuticals、Taro Pharmaceuticals、BIOMES PHARMACEUTICALS、H.J. Harkins Company、Directrx、Teva Pharmaceuticals、Fougera Pharmaceuticals、Profcient、Remedy Repack、Lohxa、Nucare Pharmaceuticals、Sino-american Tianjin Shike Pharmaceutical、Hangzhou Zhuyangxin Pharmaceutical、Hubei Renfu Chengtian Pharmaceutical、Hong Kong Aomei Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：クリーム、軟膏、その他
・用途別分析2017年-2028年：一次感染、二次感染
・ムピロシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ムピロシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ムピロシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ムピロシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ムピロシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Mupirocin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Mupirocin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Primary Infection accounting for % of the Mupirocin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cream segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Mupirocin include GSK, Medimetriks Pharmaceuticals, Cardinal Health, Ortho-McNeil Pharmaceutical, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mupirocin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cream
Ointment
Other
Market segment by Application can be divided into
Primary Infection
Secondary Infection
The key market players for global Mupirocin market are listed below:
GSK
Medimetriks Pharmaceuticals
Cardinal Health
Ortho-McNeil Pharmaceutical
Glenmark Pharmaceuticals
Taro Pharmaceuticals
BIOMES PHARMACEUTICALS
H.J. Harkins Company
Directrx
Teva Pharmaceuticals
Fougera Pharmaceuticals
Profcient
Remedy Repack
Lohxa
Nucare Pharmaceuticals
Sino-american Tianjin Shike Pharmaceutical
Hangzhou Zhuyangxin Pharmaceutical
Hubei Renfu Chengtian Pharmaceutical
Hong Kong Aomei Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mupirocin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mupirocin, with price, sales, revenue and global market share of Mupirocin from 2019 to 2022.
Chapter 3, the Mupirocin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mupirocin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mupirocin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mupirocin.
Chapter 13, 14, and 15, to describe Mupirocin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Mupirocin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mupirocin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cream
1.2.3 Ointment
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Mupirocin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Primary Infection
1.3.3 Secondary Infection
1.4 Global Mupirocin Market Size & Forecast
1.4.1 Global Mupirocin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mupirocin Sales in Volume (2017-2028)
1.4.3 Global Mupirocin Price (2017-2028)
1.5 Global Mupirocin Production Capacity Analysis
1.5.1 Global Mupirocin Total Production Capacity (2017-2028)
1.5.2 Global Mupirocin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mupirocin Market Drivers
1.6.2 Mupirocin Market Restraints
1.6.3 Mupirocin Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Mupirocin Product and Services
2.1.4 GSK Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medimetriks Pharmaceuticals
2.2.1 Medimetriks Pharmaceuticals Details
2.2.2 Medimetriks Pharmaceuticals Major Business
2.2.3 Medimetriks Pharmaceuticals Mupirocin Product and Services
2.2.4 Medimetriks Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cardinal Health
2.3.1 Cardinal Health Details
2.3.2 Cardinal Health Major Business
2.3.3 Cardinal Health Mupirocin Product and Services
2.3.4 Cardinal Health Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ortho-McNeil Pharmaceutical
2.4.1 Ortho-McNeil Pharmaceutical Details
2.4.2 Ortho-McNeil Pharmaceutical Major Business
2.4.3 Ortho-McNeil Pharmaceutical Mupirocin Product and Services
2.4.4 Ortho-McNeil Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Mupirocin Product and Services
2.5.4 Glenmark Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Taro Pharmaceuticals
2.6.1 Taro Pharmaceuticals Details
2.6.2 Taro Pharmaceuticals Major Business
2.6.3 Taro Pharmaceuticals Mupirocin Product and Services
2.6.4 Taro Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 BIOMES PHARMACEUTICALS
2.7.1 BIOMES PHARMACEUTICALS Details
2.7.2 BIOMES PHARMACEUTICALS Major Business
2.7.3 BIOMES PHARMACEUTICALS Mupirocin Product and Services
2.7.4 BIOMES PHARMACEUTICALS Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 H.J. Harkins Company
2.8.1 H.J. Harkins Company Details
2.8.2 H.J. Harkins Company Major Business
2.8.3 H.J. Harkins Company Mupirocin Product and Services
2.8.4 H.J. Harkins Company Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Directrx
2.9.1 Directrx Details
2.9.2 Directrx Major Business
2.9.3 Directrx Mupirocin Product and Services
2.9.4 Directrx Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceuticals
2.10.1 Teva Pharmaceuticals Details
2.10.2 Teva Pharmaceuticals Major Business
2.10.3 Teva Pharmaceuticals Mupirocin Product and Services
2.10.4 Teva Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Fougera Pharmaceuticals
2.11.1 Fougera Pharmaceuticals Details
2.11.2 Fougera Pharmaceuticals Major Business
2.11.3 Fougera Pharmaceuticals Mupirocin Product and Services
2.11.4 Fougera Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Profcient
2.12.1 Profcient Details
2.12.2 Profcient Major Business
2.12.3 Profcient Mupirocin Product and Services
2.12.4 Profcient Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Remedy Repack
2.13.1 Remedy Repack Details
2.13.2 Remedy Repack Major Business
2.13.3 Remedy Repack Mupirocin Product and Services
2.13.4 Remedy Repack Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lohxa
2.14.1 Lohxa Details
2.14.2 Lohxa Major Business
2.14.3 Lohxa Mupirocin Product and Services
2.14.4 Lohxa Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Nucare Pharmaceuticals
2.15.1 Nucare Pharmaceuticals Details
2.15.2 Nucare Pharmaceuticals Major Business
2.15.3 Nucare Pharmaceuticals Mupirocin Product and Services
2.15.4 Nucare Pharmaceuticals Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sino-american Tianjin Shike Pharmaceutical
2.16.1 Sino-american Tianjin Shike Pharmaceutical Details
2.16.2 Sino-american Tianjin Shike Pharmaceutical Major Business
2.16.3 Sino-american Tianjin Shike Pharmaceutical Mupirocin Product and Services
2.16.4 Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Hangzhou Zhuyangxin Pharmaceutical
2.17.1 Hangzhou Zhuyangxin Pharmaceutical Details
2.17.2 Hangzhou Zhuyangxin Pharmaceutical Major Business
2.17.3 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product and Services
2.17.4 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Hubei Renfu Chengtian Pharmaceutical
2.18.1 Hubei Renfu Chengtian Pharmaceutical Details
2.18.2 Hubei Renfu Chengtian Pharmaceutical Major Business
2.18.3 Hubei Renfu Chengtian Pharmaceutical Mupirocin Product and Services
2.18.4 Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Hong Kong Aomei Pharmaceutical
2.19.1 Hong Kong Aomei Pharmaceutical Details
2.19.2 Hong Kong Aomei Pharmaceutical Major Business
2.19.3 Hong Kong Aomei Pharmaceutical Mupirocin Product and Services
2.19.4 Hong Kong Aomei Pharmaceutical Mupirocin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mupirocin Breakdown Data by Manufacturer
3.1 Global Mupirocin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mupirocin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mupirocin
3.4 Market Concentration Rate
3.4.1 Top 3 Mupirocin Manufacturer Market Share in 2021
3.4.2 Top 6 Mupirocin Manufacturer Market Share in 2021
3.5 Global Mupirocin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mupirocin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mupirocin Market Size by Region
4.1.1 Global Mupirocin Sales in Volume by Region (2017-2028)
4.1.2 Global Mupirocin Revenue by Region (2017-2028)
4.2 North America Mupirocin Revenue (2017-2028)
4.3 Europe Mupirocin Revenue (2017-2028)
4.4 Asia-Pacific Mupirocin Revenue (2017-2028)
4.5 South America Mupirocin Revenue (2017-2028)
4.6 Middle East and Africa Mupirocin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mupirocin Sales in Volume by Type (2017-2028)
5.2 Global Mupirocin Revenue by Type (2017-2028)
5.3 Global Mupirocin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mupirocin Sales in Volume by Application (2017-2028)
6.2 Global Mupirocin Revenue by Application (2017-2028)
6.3 Global Mupirocin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mupirocin Sales by Type (2017-2028)
7.2 North America Mupirocin Sales by Application (2017-2028)
7.3 North America Mupirocin Market Size by Country
7.3.1 North America Mupirocin Sales in Volume by Country (2017-2028)
7.3.2 North America Mupirocin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mupirocin Sales by Type (2017-2028)
8.2 Europe Mupirocin Sales by Application (2017-2028)
8.3 Europe Mupirocin Market Size by Country
8.3.1 Europe Mupirocin Sales in Volume by Country (2017-2028)
8.3.2 Europe Mupirocin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mupirocin Sales by Type (2017-2028)
9.2 Asia-Pacific Mupirocin Sales by Application (2017-2028)
9.3 Asia-Pacific Mupirocin Market Size by Region
9.3.1 Asia-Pacific Mupirocin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mupirocin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mupirocin Sales by Type (2017-2028)
10.2 South America Mupirocin Sales by Application (2017-2028)
10.3 South America Mupirocin Market Size by Country
10.3.1 South America Mupirocin Sales in Volume by Country (2017-2028)
10.3.2 South America Mupirocin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mupirocin Sales by Type (2017-2028)
11.2 Middle East & Africa Mupirocin Sales by Application (2017-2028)
11.3 Middle East & Africa Mupirocin Market Size by Country
11.3.1 Middle East & Africa Mupirocin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mupirocin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mupirocin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mupirocin
12.3 Mupirocin Production Process
12.4 Mupirocin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mupirocin Typical Distributors
13.3 Mupirocin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のボルタレン市場2022年：市場規模予測（～2028年）
  • 世界のアトルバスタチンジエポキシドカルシウム塩市場2022年：市場規模予測（～2028年）
  • 世界の便秘下剤市場2022年：市場規模予測（～2028年）
  • 世界のレクサプロ市場2022年：市場規模予測（～2028年）
  • 世界のバンコマイシン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8898 )"世界のムピロシン市場2022年：市場規模予測（～2028年）" (英文：Global Mupirocin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。